Tirzepatide is a groundbreaking pharmaceutical agent for individuals battling type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://tayabfrj333941.blog2news.com/41064209/tirzepatide-a-novel-glp-1-and-gip-receptor-agonist